🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $AFX.DE and executed a BUY strategy, securing a +11.76% net profit.

UPGRADE TO SEE LIVE SIGNALS

$ENGN

enGene Therapeutics Inc.

CanadaCANADA
FREE PREVIEW
📅 Next Earnings: Sep 14, 2026 ☀️ Open🌐 Website🏛️ NASDAQ📁 Healthcare🏭 Biotechnology
AVG HISTORICAL GAP2.59%
MAX GAP RECORD9.73%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.9%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL
AI MARKET SCANNING